Showing results (2001-2010 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 7, 2012
Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and managementRachel E Seltman, Brandy R MatthewsCNS Drugs|July 13, 2012
OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraineKatherine A Lyseng-Williamson, James E FramptonCNS Drugs|May 3, 2023
Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial HemorrhageSenta Frol, Janja Pretnar Oblak, Mišo Šabovič, et al.CNS Drugs|July 24, 2020
Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled DesignMin Wu, Cuiyun Li, Hong Zhang, et al.CNS Drugs|July 26, 2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension StudyTjalf Ziemssen, Ann D Bass, Regina Berkovich, et al.CNS Drugs|August 13, 2020
Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current ApproachesJoshua T KantrowitzCNS Drugs|August 15, 2020
Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?Ajay KapurCNS Drugs|June 27, 2012
Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and managementAnna K Jönsson, Olav Spigset, Staffan HäggCNS Drugs|March 22, 2015
Statin treatment in multiple sclerosis: a systematic review and meta-analysisGorm Pihl-Jensen, Anna Tsakiri, Jette Lautrup FrederiksenCNS Drugs|January 31, 2015
mTOR inhibition in epilepsy: rationale and clinical perspectivesAdam P Ostendorf, Michael WongPageof 211